{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:20:05Z","timestamp":1774923605532,"version":"3.50.1"},"reference-count":34,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,6,3]],"date-time":"2004-06-03T00:00:00Z","timestamp":1086220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2004,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the efficacy and safety of lamivudine, an antiviral agent that strongly inhibits hepatitis B virus (HBV) DNA replication, combined with plasma exchanges after short\u2010term corticosteroids for HBV\u2010related polyartertitis nodosa (PAN).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Ten patients (8 men, 2 women, mean \u00b1 SD age 50.4 \u00b1 14.4 years) with previously untreated HBV\u2010related PAN were included in a multicenter, prospective, observational trial. Oral prednisone (1 mg\/kg\/day) was given for 1 week, then tapered and withdrawn within 1 week. Then, lamivudine (100 mg\/day or less in the case of renal insufficiency) was started for a maximum of 6 months. Plasma exchanges were performed simultaneously and scheduled as follows: 3\/week for 3 weeks, 2\/week for 2 weeks, then 1\/week until hepatitis B e antigen (HBeAg) to anti\u2010HBe antibody (HBeAb) seroconversion was obtained or until 2\u20133 months of clinical recovery was sustained. The primary trial endpoint was clinical recovery from HBV\u2010PAN at 6 months. The secondary endpoint was loss of detectable serum HBeAg and HBV DNA, and HBeAg to HBeAb seroconversion at 9 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One death, attributed to catheter\u2010related septicemia, was recorded. At 6 months, all 9 survivors had achieved clinical recovery and by 9 months, 6 of 9 (66%) had seroconverted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The strategy of short\u2010term steroids followed by lamivudine and plasma exchanges effectively led to recovery from HBV\u2010PAN. Because of its oral administration and good safety profile, lamivudine should henceforth be considered the antiviral agent of choice to treat HBV\u2010related PAN.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.20401","type":"journal-article","created":{"date-parts":[[2004,6,3]],"date-time":"2004-06-03T19:03:30Z","timestamp":1086289410000},"page":"482-487","source":"Crossref","is-referenced-by-count":119,"title":["Short\u2010term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus\u2013related polyarteritis nodosa"],"prefix":"10.1002","volume":"51","author":[{"given":"L.","family":"Guillevin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Larroche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Queyrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Loustaud\u2010Ratti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hausfater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Roudier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bielefeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Petitjean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Smadja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The French Vasculitis Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,6,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370206"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(70)90339-9"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840090116"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1970.tb01550.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20077"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-1-12"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.3.1202a.bloodjournal8731202a"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1159\/000199398"},{"key":"e_1_2_6_10_2","first-page":"1136","article-title":"Chemotherapy and hepatitis B","volume":"2","year":"1989","journal-title":"Lancet"},{"key":"e_1_2_6_11_2","first-page":"1527","article-title":"Superiority of a new etiopathogenic treatment curing periarteritis nodosa caused by hepatitis B virus, using a combination of brief corticotherapy, vidarabine and plasma exchange","volume":"17","author":"Tr\u00e9po C","year":"1988","journal-title":"Presse M\u00e9d"},{"key":"e_1_2_6_12_2","first-page":"1522","article-title":"P\u00e9riart\u00e9rite noueuse due au virus de l'h\u00e9patite B: d\u00e9termination d'une nouvelle strat\u00e9gie th\u00e9rapeutique chez 13 patients","volume":"17","author":"Guillevin L","year":"1988","journal-title":"Presse M\u00e9d"},{"key":"e_1_2_6_13_2","first-page":"289","article-title":"Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges: a prospective trial in 33 patients","volume":"20","author":"Guillevin L","year":"1993","journal-title":"J Rheumatol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.53.5.334"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290321"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807093390201"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910213411702"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(01)02265-5"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2002.35555"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6346(02)00009-8"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330805"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199601000-00003"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840010511"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)91883-6"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199509000-00002"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/151.4.599"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.4.562"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.25084"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(200001)60:1<8::AID-JMV2>3.0.CO;2-U"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00145-3"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v8.i5.868"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.2.183"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80025-2"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.2.391"}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.20401","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.20401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T17:10:52Z","timestamp":1697476252000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.20401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,6,15]]}},"alternative-id":["10.1002\/art.20401"],"URL":"https:\/\/doi.org\/10.1002\/art.20401","archive":["Portico"],"relation":{},"ISSN":["0893-7524","1529-0123"],"issn-type":[{"value":"0893-7524","type":"print"},{"value":"1529-0123","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,3]]}}}